drugset / Trial / NCT00156312
Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine
Non-randomizedSingle-groupOpen-label
Summary
The purpose of this study is to determine whether the combination of the drugs docetaxel and capecitabine is effective in treating breast cancer patients.
Timeline
- Start
- 2003-07
- Primary completion
- 2005-05
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | — | — |
| Subject | Docetaxel | Small molecule | — | — |